Annualized recurring revenue ('ARR”) of $840 millionFull-year revenue of $860 million, increased 2% year-over-yearFull-year net cash provided by operating activities of $154 million; free cash flow of ...
Payment schedules, such as a month-to-month option, provide more flexibility, especially during periods of low cash flow. Make sure the pricing structure is transparent, and opt for a month-to-month ...
In the Cleats & Cashflows section, we look at the opportunities offered by private equity, but also at the risks involved.
The Consolidated Appropriations Act of 2026 acts as a first step in addressing prescription drug pricing challenges related to the role of pharmacy benefit managers (PBMs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results